Torsten Malmström
Net worth: 2 M $ as of 2026-05-30
Net worth: 2 M $ as of 2026-05-30
Torsten Malmström formerly worked at Zealand Pharma A, as Director-Pharmaceutical Development, PolyPeptide Laboratories (Sweden) AB, as Development Director, AstraZeneca AB, as Team Manager, and Camurus AB, as Vice President-Technical Operations.
Dr. Malmström received his doctorate degree from the University of Lund.
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
CAMURUS AB 0.06% | 2024-12-30 | 35,363 ( 0.06% ) | 2 M $ | 2026-05-30 |
| Companies | Position | End |
|---|---|---|
AstraZeneca AB
AstraZeneca AB Miscellaneous Commercial ServicesCommercial Services Researches and develops pharmaceutical products | Corporate Officer/Principal | - |
PolyPeptide Laboratories (Sweden) AB
PolyPeptide Laboratories (Sweden) AB BiotechnologyHealth Technology Manufactures polypeptide, custom peptide synthesis, peptide synthesis and generic peptides | Corporate Officer/Principal | - |
| ZEALAND PHARMA A/S | Corporate Officer/Principal | - |
| CAMURUS AB | Chief Tech/Sci/R&D Officer | - |
Active
Inactive
Listed companies
Private companies
| Private companies | 5 |
|---|---|
AstraZeneca AB
AstraZeneca AB Miscellaneous Commercial ServicesCommercial Services Researches and develops pharmaceutical products | Commercial Services |
Zealand Pharma A/S
Zealand Pharma A/S BiotechnologyHealth Technology Operates as a biotechnology company that discovers and develops peptide based medicines | Health Technology |
Camurus AB
Camurus AB Pharmaceuticals: MajorHealth Technology Provides nanoscale drug delivery systems for development of high value therapeutics | Health Technology |
University of Lund
University of Lund Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
PolyPeptide Laboratories (Sweden) AB
PolyPeptide Laboratories (Sweden) AB BiotechnologyHealth Technology Manufactures polypeptide, custom peptide synthesis, peptide synthesis and generic peptides | Health Technology |
Select your edition
All financial news and data tailored to specific country editions